Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Accomplishments in 2008 in the management of curable metastatic colorectal cancer.

Literature DB >> 20011559

Accomplishments in 2008 in the management of curable metastatic colorectal cancer.

René Adam¹, Emir Hoti, Gunnar Folprecht, Al B Benson.

Abstract

Overview of the Disease IncidencePrognosisCurrent Therapy Standards Colorectal Liver Metastases (CRLM) Resectable TumorsStrategies to Convert Nonresectable Liver Metastases to Resectable StatusSynchronous Colorectal Liver MetastasesPredictors of Survival After Resection of CRLMPeritoneal Carcinomatosis (PC) From Colorectal CancerColorectal Pulmonary Metastases (CRPM)Colorectal Liver Metastases With Extrahepatic DiseaseAccomplishments (or Lack of Accomplishments) During the Year Therapy New Staging SystemSystemic Chemotherapy in Resectable Liver MetastasesSystemic Chemotherapy in Nonresectable Liver MetastasesSelective Internal Radiation Therapy (SIRT)Selection of Patients for Liver ResectionRadiofrequency AblationBiomarkersWhat Needs To Be Done? Optimizing Patient CareFuture Directions Comments on ResearchObstacles to Overcome.

Entities: Disease Species

Year: 2009 PMID： 20011559 PMCID： PMC2791382

Source DB: PubMed Journal: Gastrointest Cancer Res ISSN： 1934-7820

62 in total

1. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer.

Authors: D Elias; E Benizri; M Pocard; M Ducreux; V Boige; P Lasser
Journal: Eur J Surg Oncol Date: 2006-04-18 Impact factor: 4.424

2. The impact of margins on outcome after hepatic resection for colorectal metastasis.

Authors: Chandrakanth Are; Mithat Gonen; Kathleen Zazzali; Ronald P Dematteo; William R Jarnagin; Yuman Fong; Leslie H Blumgart; Michael D'Angelica
Journal: Ann Surg Date: 2007-08 Impact factor: 12.969

3. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect.

Authors: Dominique Elias; Gabriel Liberale; Déwi Vernerey; Marc Pocard; Michel Ducreux; Valérie Boige; David Malka; Jean-Pierre Pignon; Philippe Lasser
Journal: Ann Surg Oncol Date: 2005-09-26 Impact factor: 5.344

4. Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections.

Authors: J Figueras; F Burdio; E Ramos; J Torras; L Llado; S Lopez-Ben; A Codina-Barreras; S Mojal
Journal: Ann Oncol Date: 2007-04-13 Impact factor: 32.976

5. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis.

Authors: Ming-Shian Tsai; Yen-Hao Su; Ming-Chih Ho; Jin-Tung Liang; Tzu-Ping Chen; Hong-Shiee Lai; Po-Huang Lee
Journal: Ann Surg Oncol Date: 2006-11-14 Impact factor: 5.344

6. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

Authors: René Adam; Gerard Pascal; Denis Castaing; Daniel Azoulay; Valerie Delvart; Bernard Paule; Francis Levi; Henri Bismuth
Journal: Ann Surg Date: 2004-12 Impact factor: 12.969

7. Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

Authors: Eric Van Cutsem; Roberto Labianca; György Bodoky; Carlo Barone; Enrique Aranda; Bernard Nordlinger; Claire Topham; Josep Tabernero; Thierry André; Alberto F Sobrero; Enrico Mini; Richard Greil; Francesco Di Costanzo; Laurence Collette; Laura Cisar; Xiaoxi Zhang; David Khayat; Carsten Bokemeyer; Arnaud D Roth; David Cunningham
Journal: J Clin Oncol Date: 2009-05-18 Impact factor: 44.544

8. Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases.

Authors: M Ychou; F Viret; A Kramar; F Desseigne; E Mitry; R Guimbaud; J R Delpero; M Rivoire; F Quénet; G Portier; B Nordlinger
Journal: Cancer Chemother Pharmacol Date: 2007-09-28 Impact factor: 3.333

9. Factors influencing the natural history of colorectal liver metastases.

Authors: R Stangl; A Altendorf-Hofmann; R M Charnley; J Scheele
Journal: Lancet Date: 1994-06-04 Impact factor: 79.321

10. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival.

Authors: Yun Shin Chun; Jean-Nicolas Vauthey; Dario Ribero; Matteo Donadon; John T Mullen; Cathy Eng; David C Madoff; David Z Chang; Linus Ho; Scott Kopetz; Steven H Wei; Steven A Curley; Eddie K Abdalla
Journal: J Gastrointest Surg Date: 2007-09-11 Impact factor: 3.452

11 in total

1. Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes.

Authors: Constantinos T Sofocleous; Elena G Violari; Vlasios S Sotirchos; Waleed Shady; Mithat Gonen; Neeta Pandit-Taskar; Elena N Petre; Lynn A Brody; William Alago; Richard K Do; Michael I D'Angelica; Joseph R Osborne; Neil H Segal; Jorge A Carrasquillo; Nancy E Kemeny
Journal: Clin Colorectal Cancer Date: 2015-06-27 Impact factor: 4.481

2. Resection and reconstruction of the inferior vena cava for neoplasms.

Authors: Nikola Nikolov Vladov; Vassil Ivanov Mihaylov; Nikolai Vassilev Belev; Ventzislav Metodiev Mutafchiiski; Ivelin Rumenov Takorov; Sergei Kirilov Sergeev; Evelina Hristova Odisseeva
Journal: World J Gastrointest Surg Date: 2012-04-27

3. Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer.

Authors: Alfonso De Stefano; Chiara Carlomagno
Journal: World J Gastroenterol Date: 2014-08-07 Impact factor: 5.742

4. Effectiveness of surgery in liver metastasis from colorectal cancer: experience and results of a continuous improvement process.

Authors: F Navarro-Freire; P Navarro-Sánchez; N García-Agua; B Pérez-Cabrera; A Palomeque-Jiménez; J A Jiménez-Rios; P A García-López; A J García-Ruiz
Journal: Clin Transl Oncol Date: 2015-03-17 Impact factor: 3.405

Review 5. Multisciplinary management of patients with liver metastasis from colorectal cancer.

Authors: Kathleen De Greef; Christian Rolfo; Antonio Russo; Thiery Chapelle; Giuseppe Bronte; Francesco Passiglia; Andreia Coelho; Konstantinos Papadimitriou; Marc Peeters
Journal: World J Gastroenterol Date: 2016-08-28 Impact factor: 5.742

Review 6. Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer.

Authors: Wubin Zheng; Fan Wu; Kai Fu; Guangshun Sun; Guoqiang Sun; Xiao Li; Wei Jiang; Hongyong Cao; Hanjin Wang; Weiwei Tang
Journal: Onco Targets Ther Date: 2021-05-06 Impact factor: 4.147

7. The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer.

Authors: Irene Grossmann; Joost M Klaase; Johannes Ka Avenarius; Ignace Hjt de Hingh; Walter Jb Mastboom; Theo Wiggers
Journal: BMC Cancer Date: 2011-10-07 Impact factor: 4.430

8. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis.

Authors: Li-Jun Wang; Zhong-Yi Zhang; Xiao-Luan Yan; Wei Yang; Kun Yan; Bao-Cai Xing
Journal: World J Surg Oncol Date: 2018-10-15 Impact factor: 2.754

9. Prognostic Significance of CDH1, FN1 and VIM for Early Recurrence in Patients with Colorectal Liver Metastasis After Liver Resection.

Authors: Aleksandar Bogdanovic; Jovana Despotovic; Danijel Galun; Nemanja Bidzic; Aleksandra Nikolic; Jovana Rosic; Zoran Krivokapic
Journal: Cancer Manag Res Date: 2021-01-11 Impact factor: 3.989

10. Novel methods for clinical risk stratification in patients with colorectal liver metastases.

Authors: Ki-Yeol Kim; Nam Kyu Kim; In-Ho Cha; Joong Bae Ahn; Jin Sub Choi; Gi-Hong Choi; Joon Suk Lim; Kang Young Lee; Seung Hyuk Baik; Byung Soh Min; Hyuk Hur; Jae Kyung Roh; Sang Joon Shin
Journal: Cancer Res Treat Date: 2014-09-11 Impact factor: 4.679